News and Announcements
Read the latest news from Northwestern University Feinberg School of Medicine’s Department of Medicine. The links below take you to articles where you can learn more about our faculty’s latest achievements, awards and honors.
Individuals born in the U.S. had a higher rate of giving birth prematurely compared to U.S. immigrants, a new Northwestern Medicine study has found.
Twelve Feinberg faculty members were named to the 2023 “Highly Cited Researchers” list, published by Clarivate Analytics. The annual list identifies investigators who have demonstrated significant influence in their field through the publication of highly cited publications during the last decade.
Some interventions designed to improve healthcare worker collaboration may not improve patient outcomes, according to a recent trial published in the Annals of Internal Medicine.
For the first time in 10 years, the American Heart Association has updated the model to predict someone’s risk of developing heart disease.
Northwestern investigators, clinicians, and people living with ALS convened in the Feinberg Pavilion for the 13th annual Les Turner Symposium on ALS to celebrate and share new scientific breakthroughs that improve the understanding of ALS and advancements in treating the disease.
Investigators led by Neil Kelleher, PhD, have developed an automated technique for imaging proteoforms in ovarian cancer, according to results published in Nature Communications.
Tirzepatide, an antidiabetic drug, was found to be effective in helping individuals who are overweight or have obesity and without diabetes lose weight in combination with other lifestyle changes, according to a recent clinical trial published in Nature Medicine.
Though treatments for allergies have historically been slow-going, recent research by Feinberg investigators has provided new hope for the future of allergy management.
A new partnership, the Chicago Biomedical Consortium Hub for Innovative Technology and Entrepreneurship in the Sciences, will help Chicago inventors transform their research into commercial products.
Northwestern Medicine scientists have developed a more effective way of creating nanotherapeutic vaccines and medicines, according to a study published in ACS Nano.
Combining immunotherapy with radiation may be a promising treatment option for patients with advanced soft tissue sarcoma, according to the results of a Northwestern Medicine clinical trial published in JAMA Oncology.
Now in its second year, Feinberg’s Research Intensive Scholarly Emphasis (RISE) program supports medical students engaging in an additional year of research during their medical school career.
Faculty, staff, trainees and students gathered to share knowledge and participate in workshops examining the future of medical education during Feinberg’s 13th annual Medical Education Day, held September 27.
Northwestern Medicine investigators have uncovered new mechanisms by which iron deficiency inhibits cell growth and proliferation in eukaryotic cells, findings that could improve the understanding of cancer growth and the development of targeted cancer therapies.
Northwestern Simulation has introduced a new curricular experience to help internal medicine residents improve skills needed for the high-acuity, high-intensity scenario of leading and managing cardiac arrests in the hospital.
In 2022, Feinberg established research into social determinants of health as a priority. To better understand the impact of social determinants of health, Feinberg investigators have been leading studies that provide new insights into how a person’s neighborhood can positively or negatively affect their health.
A combination immunotherapy treatment of nivolumab plus ipilimumab was associated with no improvement in survival for advanced cancers other than melanoma, when compared to nivolumab alone, according to a recent Northwestern Medicine meta-analysis published in JAMA Oncology.
Northwestern Medicine investigators have identified how a calcium channel in the nervous system contributes to brain inflammation, according to a study published in Nature Communications.
Northwestern University investigators have developed the first electronic device for continuously monitoring the health of transplanted organs in real time.
Naturally occurring variations near the human gene CHD1L may be linked to lower HIV-1 viral load in people of African ancestry, according to a new international, multicenter study published in Nature.
David Cella, PhD, professor of Medical Social Sciences, has been named the winner of the 2023 Tripartite Legacy Faculty Prize in Translational Science and Education.
Brian Lee, a second-year student in the Medical Scientist Training Program (MSTP), was the lead author of a study that found that a new combination therapy regimen improved survival in patients with B-cell lymphoma by 30 percent.
Debra Duquette, ’92 MS, associate professor of Medicine in the Division of Cardiology, has been named the new director of Feinberg’s Graduate Program in Genetic Counseling (GPGC), effective August 1.
The Coronary Artery Risk Development in Young Adults (CARDIA) study has received a 10-year $11 million grant renewal from the National Heart, Lung, and Blood Institute at the National Institutes of Health.
Combining immunotherapy with a tumor-targeted virus may help extend survival in some patients with recurrent glioblastoma, according to the results of a trial published in Nature Medicine.
A new Northwestern Medicine study has discovered a novel therapeutic target and therapeutic agents for older patients with acute respiratory distress syndrome, according to recent findings published in Science Translational Medicine.
The Robert H. Lurie Comprehensive Cancer Center of Northwestern University has received a renewed five-year $10.8 million Specialized Program of Research Excellence (SPORE) grant from the National Cancer Institute for the Lurie Cancer Center to advance translational research and improve outcomes for patients with brain cancer.
Marlise Pierre-Wright, ‘22 MD, MPA, an internal medicine resident at Northwestern Memorial Hospital and former medical student, has been awarded a multi-institutional grant for her project that will bolster trauma-informed care curriculum and training for residents.
A new drug used to treat cancer may also prevent allergic reactions to peanuts, according to a study published in the Journal of Clinical Investigation.